SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-18-188165
Filing Date
2018-06-08
Accepted
2018-06-08 16:39:58
Documents
4
Period of Report
2018-03-14
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d587657d8ka.htm 8-K/A 17075
2 EX-10.14 d587657dex1014.htm EX-10.14 231838
3 EX-10.17 d587657dex1017.htm EX-10.17 288016
4 GRAPHIC g587657g0608092440712.jpg GRAPHIC 4507
  Complete submission text file 0001193125-18-188165.txt   544565
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35405 | Film No.: 18889998
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences